Latest Period
Q4 2025
Security Snapshot
HAEMONETICS CORP - Common Stock (HAE) Institutional Ownership
CUSIP: 405024100
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
328
Shares (Excl. Options)
50,858,292
Price
$80.15
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- HAE on NYSE
- Shares outstanding
- 46,498,422
- Price per share
- $56.36
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 50,858,292
- Total reported value
- $4,075,774,696
- % of total 13F portfolios
- 0%
- Share change
- -460,679
- Value change
- +$58,123,004
- Number of holders
- 328
- Price from insider filings
- $56.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- HAE - HAEMONETICS CORP - Common Stock is tracked under CUSIP 405024100.
- 328 institutions reported positions in Q4 2025.
- 7 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 328 to 122 between Q4 2025 and Q1 2026.
- Reported value moved from $4,075,774,696 to $463,500,094.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 328 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 405024100:
Significant Owners of HAEMONETICS CORP - Common Stock (HAE) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC | 6.8% | $253,522,786 | 3,163,104 | AQR Capital Management, LLC | 31 Dec 2025 | |||
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.6% | $146,544,172 | 2,600,145 | Vanguard Portfolio Management | 31 Mar 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.3% | $137,846,246 | 2,445,817 | Vanguard Capital Management | 31 Mar 2026 | |||
| North Peak Capital Management, LLC | 5.1% | $154,129,585 | 2,370,495 | North Peak Capital Management, LLC | 24 Feb 2026 | |||
| WELLINGTON MANAGEMENT GROUP LLP | 4.6% | -16% | $165,537,761 | -$36,448,193 | 2,203,351 | -18% | Wellington Management Group LLP | 30 Jun 2025 |
| T. Rowe Price Investment Management, Inc. | 4.4% | $135,949,632 | 2,195,569 | T. Rowe Price Investment Management, Inc. | 31 Mar 2025 | |||
| Capital Research Global Investors | 3.1% | $97,667,840 | 1,577,323 | Capital Research Global Investors | 31 Mar 2025 |
As of 31 Dec 2025, 328 institutional investors reported holding 50,858,292 shares of HAEMONETICS CORP - Common Stock (HAE). This represents 109% of the company’s total 46,498,422 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of HAEMONETICS CORP - Common Stock (HAE) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13% | 5,820,954 | -3.3% | 0.01% | $466,549,479 |
| VANGUARD GROUP INC | 10% | 4,761,135 | -1.5% | 0.01% | $381,604,971 |
| NEUBERGER BERMAN GROUP LLC | 8.3% | 3,865,676 | +5.3% | 0.23% | $309,882,554 |
| AQR CAPITAL MANAGEMENT LLC | 6.8% | 3,163,104 | +49% | 0.13% | $253,522,786 |
| STATE STREET CORP | 3.7% | 1,729,847 | -3.9% | 0% | $138,647,237 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3% | 1,380,102 | +995% | 0.06% | $110,615,175 |
| FMR LLC | 2.9% | 1,326,902 | +9.1% | 0.01% | $106,351,232 |
| CITADEL ADVISORS LLC | 2.8% | 1,288,432 | +482% | 0.07% | $103,267,825 |
| Holocene Advisors, LP | 2.7% | 1,264,271 | +3148% | 0.21% | $101,331,321 |
| GOLDMAN SACHS GROUP INC | 2.6% | 1,226,614 | +110% | 0.01% | $98,313,113 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 1,194,551 | -0.73% | 0.01% | $95,758,176 |
| North Peak Capital Management, LLC | 2.4% | 1,102,992 | +204% | 9.7% | $88,404,809 |
| River Road Asset Management, LLC | 2.4% | 1,102,140 | -33% | 0.97% | $88,336,521 |
| DIMENSIONAL FUND ADVISORS LP | 2.4% | 1,092,938 | -0.6% | 0.02% | $87,602,682 |
| ROYAL BANK OF CANADA | 2.1% | 967,593 | -23% | 0.01% | $77,553,000 |
| T. Rowe Price Investment Management, Inc. | 2% | 943,185 | -6.7% | 0.05% | $75,597,000 |
| Allspring Global Investments Holdings, LLC | 2% | 939,727 | -11% | 0.12% | $75,159,365 |
| Point72 Asset Management, L.P. | 1.8% | 853,379 | +1882% | 0.11% | $68,398,327 |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 1.5% | 716,997 | +1.5% | 0.31% | $57,467,310 |
| Boston Trust Walden Corp | 1.2% | 580,650 | -39% | 0.35% | $46,539,097 |
| NORTHERN TRUST CORP | 1.2% | 577,728 | -4.1% | 0.01% | $46,304,898 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.2% | 573,653 | -11% | 0.32% | $45,978,539 |
| CITIGROUP INC | 1.2% | 569,173 | +33% | 0.03% | $45,619,216 |
| MORGAN STANLEY | 1.2% | 562,949 | +8.1% | 0% | $45,120,430 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2% | 548,921 | -2.3% | 0.01% | $43,996,018 |
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 8,225,854 | $463,500,094 | +$34,495,484 | $56.36 | 122 |
| 2025 Q4 | 50,858,292 | $4,075,774,696 | +$58,123,004 | $80.15 | 328 |
| 2025 Q3 | 51,319,539 | $2,500,166,518 | -$232,706,500 | $48.74 | 298 |
| 2025 Q2 | 54,253,774 | $4,048,407,950 | +$51,089,014 | $74.61 | 297 |
| 2025 Q1 | 53,724,229 | $3,412,895,600 | -$212,763,194 | $63.55 | 313 |
| 2024 Q4 | 56,558,011 | $4,415,683,452 | +$40,389,204 | $78.08 | 305 |
| 2024 Q3 | 55,858,330 | $4,486,624,929 | -$21,003,128 | $80.38 | 303 |
| 2024 Q2 | 55,851,715 | $4,621,294,419 | +$385,980,667 | $82.73 | 315 |
| 2024 Q1 | 51,176,074 | $4,367,618,453 | +$50,781,270 | $85.35 | 296 |
| 2023 Q4 | 50,568,886 | $4,325,205,912 | -$20,996,057 | $85.51 | 294 |
| 2023 Q3 | 50,792,206 | $4,551,407,114 | +$20,351,169 | $89.58 | 294 |
| 2023 Q2 | 50,542,703 | $4,303,570,562 | +$14,249,115 | $85.14 | 288 |
| 2023 Q1 | 50,384,868 | $4,169,004,070 | +$9,612,280 | $82.75 | 294 |
| 2022 Q4 | 50,382,562 | $3,963,254,277 | -$107,357,997 | $78.65 | 287 |
| 2022 Q3 | 51,775,808 | $3,833,648,345 | -$28,085,090 | $74.03 | 260 |
| 2022 Q2 | 52,080,593 | $3,394,785,256 | +$49,689,135 | $65.18 | 229 |
| 2022 Q1 | 51,567,377 | $3,257,869,910 | +$120,748,445 | $63.22 | 225 |
| 2021 Q4 | 50,084,803 | $2,655,680,021 | -$87,203,336 | $53.04 | 240 |
| 2021 Q3 | 50,697,310 | $3,576,779,438 | +$7,330,940 | $70.59 | 239 |
| 2021 Q2 | 50,672,122 | $3,375,443,272 | -$52,557,812 | $66.64 | 249 |
| 2021 Q1 | 49,961,531 | $5,549,106,460 | -$22,300,347 | $111.01 | 288 |
| 2020 Q4 | 49,701,181 | $5,902,338,582 | +$13,637,273 | $118.75 | 278 |
| 2020 Q3 | 49,419,749 | $4,312,359,704 | -$6,823,951 | $87.25 | 261 |
| 2020 Q2 | 49,513,911 | $4,436,797,359 | -$134,065,133 | $89.56 | 276 |
| 2020 Q1 | 50,595,124 | $5,040,192,796 | +$54,162,521 | $99.66 | 263 |
| 2019 Q4 | 49,844,997 | $5,726,892,199 | -$8,413,468 | $114.90 | 291 |
| 2019 Q3 | 49,617,874 | $6,258,106,643 | -$157,378,824 | $126.14 | 271 |
| 2019 Q2 | 50,896,394 | $6,124,009,590 | +$58,035,871 | $120.34 | 253 |
| 2019 Q1 | 51,283,498 | $4,486,016,605 | +$62,307,595 | $87.48 | 253 |
| 2018 Q4 | 50,443,395 | $5,047,277,313 | -$147,988,434 | $100.05 | 277 |
| 2018 Q3 | 51,715,308 | $5,924,362,043 | +$210,608,325 | $114.58 | 289 |
| 2018 Q2 | 50,368,130 | $4,517,192,617 | -$185,243,709 | $89.68 | 289 |
| 2018 Q1 | 52,583,034 | $3,847,182,644 | +$17,637,230 | $73.16 | 254 |
| 2017 Q4 | 53,625,853 | $3,115,125,238 | -$26,066,940 | $58.08 | 240 |
| 2017 Q3 | 54,786,766 | $2,458,102,091 | -$29,442,951 | $44.87 | 203 |
| 2017 Q2 | 55,471,370 | $2,190,580,845 | +$31,076,045 | $39.49 | 190 |
| 2017 Q1 | 54,635,388 | $2,216,655,714 | +$337,134,900 | $40.57 | 176 |
| 2016 Q4 | 52,451,093 | $2,108,521,648 | +$26,285,233 | $40.20 | 192 |
| 2016 Q3 | 51,805,572 | $1,875,274,739 | +$32,082,627 | $36.21 | 176 |
| 2016 Q2 | 50,973,144 | $1,478,067,581 | -$32,032,171 | $28.99 | 169 |
| 2016 Q1 | 51,250,356 | $1,791,862,985 | +$9,515,385 | $34.98 | 160 |
| 2015 Q4 | 51,190,608 | $1,650,317,369 | -$35,481,356 | $32.24 | 158 |
| 2015 Q3 | 52,124,856 | $1,684,666,056 | -$42,369,690 | $32.32 | 168 |
| 2015 Q2 | 53,401,411 | $2,208,658,190 | -$15,026,392 | $41.36 | 176 |
| 2015 Q1 | 53,751,288 | $2,413,804,087 | -$14,774,340 | $44.92 | 166 |
| 2014 Q4 | 54,180,608 | $2,027,372,717 | +$29,529,104 | $37.42 | 171 |
| 2014 Q3 | 53,079,424 | $1,853,545,493 | -$47,792,045 | $34.92 | 168 |
| 2014 Q2 | 54,462,831 | $1,921,442,064 | +$18,983,073 | $35.28 | 172 |
| 2014 Q1 | 54,173,562 | $1,765,475,443 | -$102,994,220 | $32.59 | 187 |